Regeneron Pharmaceuticals Net Income Per Employee
- Regeneron Pharmaceuticals's annual net income per employee was - in fiscal year 2026. The net income per employee decreased $298.22 K from $298.22 K (in 2025) to - (in 2026), representing a -100.00% year-over-year decline.
- The Highest net income per employee for Regeneron Pharmaceuticals was $885.16 K in fiscal year 2021.
- The Lowest net income per employee was - in fiscal year 2026.
- The Average net income per employee was $359.94 K.
- Net Income per Employee is the amount of profit that a business earns from one employee. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2017-2026):
Learn more about Regeneron Pharmaceuticals's Revenue by Segment and Revenue by Region.
Check out competitors to Regeneron Pharmaceuticals in a side-by-side comparison.
Explore additional financial metrics for Regeneron Pharmaceuticals.
Definition of Net Income per Employee :
Regeneron Pharmaceuticals's Net Income Per Employee Trend
| 2016 | 208260.93023256 |
|---|---|
| 2017 | 221946.48148148 |
| 2018 | 394258.06451613 |
| 2019 | 285918.91891892 |
| 2020 | 433728.39506173 |
| 2021 | 885158.39088019 |
| 2022 | 418441.35802469 |
| 2023 | 333608.9781453 |
| 2024 | 328074.34944238 |
| 2025 | 298219.25062889 |
| 2026 | 0 |
2026
Regeneron Pharmaceuticals's net income per employee was - in fiscal year 2026.
2025
Regeneron Pharmaceuticals's net income per employee was $298.22 K in fiscal year 2025.
2024
Regeneron Pharmaceuticals's net income per employee was $328.07 K in fiscal year 2024.
2023
Regeneron Pharmaceuticals's net income per employee was $333.61 K in fiscal year 2023.
2022
Regeneron Pharmaceuticals's net income per employee was $418.44 K in fiscal year 2022.
2021
Regeneron Pharmaceuticals's net income per employee was $885.16 K in fiscal year 2021.
2020
Regeneron Pharmaceuticals's net income per employee was $433.73 K in fiscal year 2020.
2019
Regeneron Pharmaceuticals's net income per employee was $285.92 K in fiscal year 2019.
2018
Regeneron Pharmaceuticals's net income per employee was $394.26 K in fiscal year 2018.
2017
Regeneron Pharmaceuticals's net income per employee was $221.95 K in fiscal year 2017.
Regeneron Pharmaceuticals's Net Income Per Employee (Year-over-Year Change)
| 2017 | 6.57 |
|---|---|
| 2018 | 77.64 |
| 2019 | -27.48 |
| 2020 | 51.7 |
| 2021 | 104.08 |
| 2022 | -52.73 |
| 2023 | -20.27 |
| 2024 | -1.66 |
| 2025 | -9.1 |
| 2026 | -100 |
2026
Regeneron Pharmaceuticals's net income per employee
decreased
-100% during fiscal year 2026 compared to
2025.
It represents a decline of
-$298.22 K from
$298.22 K (in
2025) to
- (in
2026).
2025
Regeneron Pharmaceuticals's net income per employee
decreased
-9.1% during fiscal year 2025 compared to
2024.
It represents a decline of
-$29.86 K from
$328.07 K (in
2024) to
$298.22 K (in
2025).
2024
Regeneron Pharmaceuticals's net income per employee
decreased
-1.66% during fiscal year 2024 compared to
2023.
It represents a decline of
-$5.53 K from
$333.61 K (in
2023) to
$328.07 K (in
2024).
2023
Regeneron Pharmaceuticals's net income per employee
decreased
-20.27% during fiscal year 2023 compared to
2022.
It represents a decline of
-$84.83 K from
$418.44 K (in
2022) to
$333.61 K (in
2023).
2022
Regeneron Pharmaceuticals's net income per employee
decreased
-52.73% during fiscal year 2022 compared to
2021.
It represents a decline of
-$466.72 K from
$885.16 K (in
2021) to
$418.44 K (in
2022).
2021
Regeneron Pharmaceuticals's net income per employee
increased
104.08% during fiscal year 2021 compared to
2020.
It represents an increase of
$451.43 K from
$433.73 K (in
2020) to
$885.16 K (in
2021).
2020
Regeneron Pharmaceuticals's net income per employee
increased
51.7% during fiscal year 2020 compared to
2019.
It represents an increase of
$147.81 K from
$285.92 K (in
2019) to
$433.73 K (in
2020).
2019
Regeneron Pharmaceuticals's net income per employee
decreased
-27.48% during fiscal year 2019 compared to
2018.
It represents a decline of
-$108.34 K from
$394.26 K (in
2018) to
$285.92 K (in
2019).
2018
Regeneron Pharmaceuticals's net income per employee
increased
77.64% during fiscal year 2018 compared to
2017.
It represents an increase of
$172.31 K from
$221.95 K (in
2017) to
$394.26 K (in
2018).
2017
Regeneron Pharmaceuticals's net income per employee
increased
6.57% during fiscal year 2017 compared to
-.
It represents an increase of
$13.69 K from
$208.26 K (in
2016) to
$221.95 K (in
2017).
Summary Table
| Period | Net Income per Employee | Year-over-Year Change |
|---|---|---|
| 2026 | - | -100% |
| 2025 | $298.22 K | -9.1% |
| 2024 | $328.07 K | -1.66% |
| 2023 | $333.61 K | -20.27% |
| 2022 | $418.44 K | -52.73% |
| 2021 | $885.16 K | +104.08% |
| 2020 | $433.73 K | +51.7% |
| 2019 | $285.92 K | -27.48% |
| 2018 | $394.26 K | +77.64% |
| 2017 | $221.95 K | +6.57% |
Related
-
Agilent Technologies Net Income per Employee
-
Eli Lilly and Company Net Income per Employee
-
Stryker Corporation Net Income per Employee
-
Johnson & Johnson Net Income per Employee
-
AbbVie Net Income per Employee
-
Merck & Co. Net Income per Employee
-
Thermo Fisher Scientific Net Income per Employee
-
Abbott Laboratories Net Income per Employee
-
Danaher Corporation Net Income per Employee
-
Amgen Net Income per Employee
